Literature DB >> 19644932

Oral cavity cancer in developed and in developing countries: population-based incidence.

Marianna de Camargo Cancela1, Lydia Voti, Marta Guerra-Yi, François Chapuis, Mathieu Mazuir, Maria Paula Curado.   

Abstract

BACKGROUND: The incidence of oral cavity cancer (OCC) is not well documented because it is rarely described in accord with the anatomic definition but is usually grouped with oropharyngeal subsites. We studied the incidence of OCC in developed and in developing countries.
METHODS: The age-standardized and age-specific incidence rates of OCC were calculated for the period 1998-2002, using the topographic definition used by the Union Internationale Contre le Cancer (UICC), based on data from CI5-IX.
RESULTS: The highest rates are observed in Pakistan, Brazil, India, and France and were consistent with country-specific risk factors and their prevalence.
CONCLUSIONS: In developing countries, people are exposed to a wider range of risk factors, starting at younger ages, and primary prevention measures and policies are needed. Awareness of professionals must be improved to identify people at risk and target them for prevention and to minimize the consequences of OCC.

Entities:  

Mesh:

Year:  2010        PMID: 19644932     DOI: 10.1002/hed.21193

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  37 in total

1.  ANXA1 affects cell proliferation, invasion and epithelial-mesenchymal transition of oral squamous cell carcinoma.

Authors:  Ying-Ming Wan; Jing Tian; Ling Qi; Li-Mei Liu; Ning Xu
Journal:  Exp Ther Med       Date:  2017-09-20       Impact factor: 2.447

Review 2.  The challenges of defining oral cancer: analysis of an ontological approach.

Authors:  Jose Luis Tapia; Louis J Goldberg
Journal:  Head Neck Pathol       Date:  2011-09-14

3.  Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma.

Authors:  Yan Guo; Yuji Ma; Xuanhao Hu; Rongbo Song; Li Zhu; Ming Zhong
Journal:  Cancer Biol Ther       Date:  2018-01-15       Impact factor: 4.742

4.  STAG2 expression in oral cancer and potentially malignant lesions.

Authors:  Vanessa Fátima Bernardes; Gefter Thiago Batista Correa; Adriano Mota Loyola; Sérgio Vitorino Cardoso; Alfredo Maurício Batista de Paula; Mônica Maria Demas Álvares Cabral; Ricardo Santiago Gomez; Carolina Cavaliéri Gomes
Journal:  Tumour Biol       Date:  2013-12-08

5.  Oral squamous cell carcinoma among Yemenis: Onset in young age and presentation at advanced stage.

Authors:  Esam Halboub; Maha Al-Mohaya; Mahmoud Abdulhuq; Ahmad Al-Mandili; Yousef Al-Anazi
Journal:  J Clin Exp Dent       Date:  2012-10-01

Review 6.  Accuracy of imaging methods for detection of bone tissue invasion in patients with oral squamous cell carcinoma.

Authors:  S Uribe; L A Rojas; C F Rosas
Journal:  Dentomaxillofac Radiol       Date:  2013-02-18       Impact factor: 2.419

7.  Technetium-99m bone scan and panoramic radiography in detection of bone invasion by oral carcinoma.

Authors:  Anshuman Suresh Jamdade; Ani John
Journal:  J Clin Diagn Res       Date:  2014-05-15

8.  Enhancing chemosensitivity in oral squamous cell carcinoma by lentivirus vector-mediated RNA interference targeting EGFR and MRP2.

Authors:  Ying-Ju Chen; Shiuan-Yin Chen; Ronald Lovel; Yi-Chu Ku; Yi-Hui Lai; Chiao-Ling Hung; Yu-Fen Li; Yin-Che Lu; Chien-Kuo Tai
Journal:  Oncol Lett       Date:  2016-07-20       Impact factor: 2.967

9.  In serum, higher parathyroid hormone but not lower vitamin D is associated with oral squamous cell carcinoma.

Authors:  H Zhang; H Lu; C Shrestha; Y Feng; Y Li; J Peng; Y Li; Z Xie
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

10.  QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2.

Authors:  Wei Lu; Feixue Feng; Jinke Xu; Xiaozhao Lu; Shan Wang; Lifeng Wang; Huanyu Lu; Mengying Wei; Guodong Yang; Li Wang; Zifan Lu; Yanpu Liu; Xiaoying Lei
Journal:  Cancer Biol Ther       Date:  2014-06-11       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.